Suppr超能文献

2010-16 年伦敦教学医院抗真菌药物管理计划的效果。

Effectiveness of an antifungal stewardship programme at a London teaching hospital 2010-16.

机构信息

Pharmacy Department, St George's University Hospitals NHS Foundation Trust, Blackshaw Road, London, UK.

Department of Infection, St George's University Hospitals NHS Foundation Trust, Blackshaw Road, London, UK.

出版信息

J Antimicrob Chemother. 2019 Jan 1;74(1):234-241. doi: 10.1093/jac/dky389.

Abstract

BACKGROUND

The need for antifungal stewardship is gaining recognition with increasing incidence of invasive fungal infection (IFI) and antifungal resistance alongside the high cost of antifungal drugs. Following an audit showing suboptimal practice we initiated an antifungal stewardship programme and prospectively evaluated its impact on clinical and financial outcomes.

PATIENTS AND METHODS

From October 2010 to September 2016, adult inpatients receiving amphotericin B, echinocandins, intravenous fluconazole, flucytosine or voriconazole were reviewed weekly by an infectious diseases consultant and antimicrobial pharmacist. Demographics, diagnosis by European Organization for Research and Treatment of Cancer (EORTC) criteria, drug, indication, advice, acceptance and in-hospital mortality were recorded. Antifungal consumption and expenditure, and candidaemia species and susceptibility data were extracted from pharmacy and microbiology databases.

RESULTS

A total of 432 patients were reviewed, most commonly receiving AmBisome® (35%) or intravenous fluconazole (29%). Empirical treatment was often unnecessary, with 82% having no evidence of IFI. Advice was given in 64% of reviews (most commonly de-escalating or stopping treatment) and was followed in 84%. Annual antifungal expenditure initially reduced by 30% (£0.98 million to £0.73 million), then increased to 20% above baseline over a 5 year period; this was a significantly lower rise compared with national figures, which showed a doubling of expenditure over the same period. Inpatient mortality, Candida species distribution and rates of resistance were not adversely affected by the intervention.

CONCLUSIONS

Provision of specialist input to optimize antifungal prescribing resulted in significant cost savings without compromising on microbiological or clinical outcomes. Our model is readily implementable by hospitals with high numbers of at-risk patients and antifungal expenditure.

摘要

背景

随着侵袭性真菌感染 (IFI) 和抗真菌药物耐药率的增加以及抗真菌药物成本的高昂,对抗真菌药物管理的需求日益受到关注。在一次审计显示出次优的实践之后,我们启动了一个抗真菌药物管理计划,并前瞻性地评估了其对临床和财务结果的影响。

患者和方法

从 2010 年 10 月到 2016 年 9 月,每周由一名传染病顾问和抗菌药剂师审查接受两性霉素 B、棘白菌素类、静脉用氟康唑、氟胞嘧啶或伏立康唑治疗的成年住院患者。记录患者的人口统计学资料、欧洲癌症研究与治疗组织 (EORTC) 标准诊断、药物、适应证、建议、接受情况和住院死亡率。从药房和微生物学数据库中提取抗真菌药物的使用和支出以及念珠菌血症的种类和药敏数据。

结果

共审查了 432 名患者,最常见的是使用两性霉素 B(35%)或静脉用氟康唑(29%)。经验性治疗通常是不必要的,82%的患者没有IFI 的证据。在 64%的审查中给出了建议(最常见的是降级或停止治疗),并在 84%的情况下得到了遵循。抗真菌药物的年度支出最初减少了 30%(从 98 万英镑降至 73 万英镑),然后在 5 年内增加到比基线高出 20%;与同期全国数据相比,这一增长幅度明显较低,同期支出增加了一倍。干预措施并未对住院死亡率、念珠菌种类分布和耐药率产生不利影响。

结论

提供专家意见以优化抗真菌药物的处方可显著节省成本,而不会影响微生物学或临床结果。我们的模式很容易被高危患者数量和抗真菌药物支出较高的医院实施。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验